We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+0.28%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$35.8B
AUM Growth
+$1.5B
(+4.4%)
Cap. Flow
+$1.13B
Cap. Flow
% of AUM
3.16%
Top 10 Holdings %
Top 10 Hldgs %
23.91%
Holding
1,455
New
69
Increased
612
Reduced
362
Closed
87
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$105M |
| 2 |
Analog Devices
ADI
|
+$93.7M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$93.4M |
| 4 |
Amazon
AMZN
|
+$90.1M |
| 5 |
UnitedHealth
UNH
|
+$84.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deutsche Bank
DB
|
+$338M |
| 2 |
Qualcomm
QCOM
|
+$110M |
| 3 |
Wells Fargo
WFC
|
+$109M |
| 4 |
Linde
LIN
|
+$86.6M |
| 5 |
Baidu
BIDU
|
+$68.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.42% |
| 2 | Healthcare | 15.85% |
| 3 | Financials | 11.31% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Vishay Intertechnology
VSH
$5.1B
| $1.13M | ﹤0.01% |
56,100
| – | – |
|
|
TPTX
877
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $1.12M | ﹤0.01% |
16,470
| – | – |
|
878
Lumentum
LITE
$63.8B
| $1.11M | ﹤0.01% |
13,350
| – | – |
|
|
BBBY
879
Bed Bath & Beyond
BBBY
$406M
| $1.09M | ﹤0.01% |
14,816
+9,460
| +177% | +$655K |
|
|
ITCI
880
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.09M | ﹤0.01% |
30,900
| – | – |
|
881
Open Text
OTEX
$5.8B
| $1.09M | ﹤0.01% |
22,271
-122,665
| -85% | -$6.4M |
|
882
Evergy
EVRG
$18.9B
| $1.09M | ﹤0.01% |
17,215
-1,252
| -7% | -$82.1K |
|
883
Nu Skin
NUS
$236M
| $1.09M | ﹤0.01% |
26,700
| – | – |
|
884
Apollo Global Management
APO
$80.8B
| $1.08M | ﹤0.01% |
17,287
+1,663
| +11% | +$99.9K |
|
885
Chemours
CC
$2.23B
| $1.08M | ﹤0.01% |
37,000
| – | – |
|
|
AGR
886
DELISTED
Avangrid, Inc.
AGR
| $1.08M | ﹤0.01% |
22,317
+21,146
| +1,806% | +$1.11M |
|
887
Arcturus Therapeutics
ARCT
$214M
| $1.08M | ﹤0.01% |
23,100
+15,000
| +185% | +$672K |
|
888
Nordson
NDSN
$17.3B
| $1.07M | ﹤0.01% |
4,364
+81
| +2% | +$18.7K |
|
889
Cenovus Energy
CVE
$55B
| $1.07M | ﹤0.01% |
107,494
+39,931
| +59% | +$341K |
|
890
Arbutus Biopharma
ABUS
$923M
| $1.06M | ﹤0.01% |
250,000
| – | – |
|
891
Sotera Health
SHC
$5.45B
| $1.06M | ﹤0.01% |
40,000
| – | – |
|
892
Aurinia Pharmaceuticals
AUPH
$2.04B
| $1.04M | ﹤0.01% |
45,600
| – | – |
|
893
Halozyme
HALO
$11.6B
| $1.04M | ﹤0.01% |
26,200
| – | – |
|
894
Schrodinger
SDGR
$1.4B
| $1.03M | ﹤0.01% |
18,800
+6,700
| +55% | +$429K |
|
|
AMRS
895
DELISTED
Amyris Inc.
AMRS
| $1.03M | ﹤0.01% |
+76,000
| New | +$1.09M |
|
|
EQC
896
DELISTED
Equity Commonwealth
EQC
| $1.01M | ﹤0.01% |
39,691
| – | – |
|
|
KRTX
897
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.01M | ﹤0.01% |
8,500
| – | – |
|
898
Saic
SAIC
$5.3B
| $1.01M | ﹤0.01% |
11,600
| – | – |
|
899
Banco Bradesco
BBD
$35B
| $997K | ﹤0.01% |
286,669
+88,000
| +44% | +$351K |
|
900
nVent Electric
NVT
$27.1B
| $997K | ﹤0.01% |
+30,200
| New | +$978K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q3 2021 Portfolio in Review
As of Q3 2021, DekaBank Deutsche Girozentrale held 1,455 positions worth $35.8B, up 4.4% from $34.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
DekaBank Deutsche Girozentrale deployed $1.13B of net new capital in Q3 2021, opening 69 new positions and adding to 612 existing holdings. Its largest new stake was Ambarella: 99,200 shares worth $15.1M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $110M trimmed.
- DekaBank Deutsche Girozentrale's largest Q3 2021 buy was Ambarella: 99,200 shares worth $15.1M.
- DekaBank Deutsche Girozentrale added most to Stellantis in Q3 2021, an estimated $105M increase.
- DekaBank Deutsche Girozentrale's biggest Q3 2021 reduction was Qualcomm, cutting an estimated $110M.
- DekaBank Deutsche Girozentrale fully exited Deutsche Bank in Q3 2021, selling an estimated $338M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 24% of its $35.8B portfolio in Q3 2021.
- DekaBank Deutsche Girozentrale opened 69 new positions and closed 87 in Q3 2021.
- DekaBank Deutsche Girozentrale's portfolio value rose 4.4% quarter-over-quarter to $35.8B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2021, filed 22 Oct 2021.